Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response

Abstract Background IgG4-related disease (IgG4-RD) is a heterogeneous autoimmune disorder characterised by inflammatory lesions. Diagnostic imaging, such as 2-[18F]FDG PET/CT, is critical in evaluation of the disease, especially for potentially lethal cardiovascular manifestations. This retrospectiv...

Full description

Bibliographic Details
Main Authors: Mingwei Chen, Charlene Yu Lin Tang, Warren Weng Seng Fong, Winnie Wing-Chuen Lam
Format: Article
Language:English
Published: SpringerOpen 2023-03-01
Series:EJNMMI Research
Subjects:
Online Access:https://doi.org/10.1186/s13550-023-00972-9
_version_ 1797863518805950464
author Mingwei Chen
Charlene Yu Lin Tang
Warren Weng Seng Fong
Winnie Wing-Chuen Lam
author_facet Mingwei Chen
Charlene Yu Lin Tang
Warren Weng Seng Fong
Winnie Wing-Chuen Lam
author_sort Mingwei Chen
collection DOAJ
description Abstract Background IgG4-related disease (IgG4-RD) is a heterogeneous autoimmune disorder characterised by inflammatory lesions. Diagnostic imaging, such as 2-[18F]FDG PET/CT, is critical in evaluation of the disease, especially for potentially lethal cardiovascular manifestations. This retrospective study examines the usefulness of semi-quantitative parameters of 2-[18F]FDG PET/CT in monitoring IgG4-RD in patients with and without cardiovascular manifestations. Methods Patients diagnosed with IgG4-RD who underwent a 2-[18F]FDG PET/CT scan were identified and classified based on presence or absence of cardiovascular disease. Clinical and laboratory data were extracted and compared to three 2-[18F]FDG PET/CT semi-quantitative parameters: maximum standardised uptake value (SUVmax), metabolic tumour volume (MTV), and total lesion glycolysis (TLG). Tissue-to-background blood (TBR) values were also evaluated for cardiovascular manifestations. These data were also compared in patients before and after receiving immunosuppressive therapy. Results Forty-six patients identified were divided into an eight member subgroup of patients with cardiovascular manifestations, and a thirty-eight member subgroup of patients without. Patients with cardiovascular lesions were most frequently identified incidentally on imaging evaluation for other diseases (37.5%), with none presenting with chest pain or other cardiovascular symptoms. Ten patients with pre-treatment and post-treatment 2-[18F]FDG PET/CT scans demonstrated significant decreases in all semi-quantitative parameters, with no significant decrease in total IgG or ESR. The decrease in SUVmax, MTV, TLG following therapy was replicated in patients with and without cardiovascular manifestations. Conclusion 2-[18F]FDG PET/CT is an important investigation to determine all sites of involvement in this multisystemic disease and to rule out life-threatening cardiovascular manifestations even in the absence of symptoms. Semi-quantitative parameters such as SUVmax, MTV, TLG, and TBR are useful in assessing treatment response in patients. There are no serological substitutes that can quantify the extent of disease involvement like 2-[18F]FDG PET/CT.
first_indexed 2024-04-09T22:37:49Z
format Article
id doaj.art-10b34d91543849f5965534ae9f699b9b
institution Directory Open Access Journal
issn 2191-219X
language English
last_indexed 2024-04-09T22:37:49Z
publishDate 2023-03-01
publisher SpringerOpen
record_format Article
series EJNMMI Research
spelling doaj.art-10b34d91543849f5965534ae9f699b9b2023-03-22T12:21:35ZengSpringerOpenEJNMMI Research2191-219X2023-03-011311810.1186/s13550-023-00972-9Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment responseMingwei Chen0Charlene Yu Lin Tang1Warren Weng Seng Fong2Winnie Wing-Chuen Lam3Lee Kong Chian School of Medicine, Nanyang Technological UniversityDepartment of Nuclear Medicine and Molecular Imaging, Singapore General HospitalDepartment of Rheumatology and Immunology, Singapore General HospitalDepartment of Nuclear Medicine and Molecular Imaging, Singapore General HospitalAbstract Background IgG4-related disease (IgG4-RD) is a heterogeneous autoimmune disorder characterised by inflammatory lesions. Diagnostic imaging, such as 2-[18F]FDG PET/CT, is critical in evaluation of the disease, especially for potentially lethal cardiovascular manifestations. This retrospective study examines the usefulness of semi-quantitative parameters of 2-[18F]FDG PET/CT in monitoring IgG4-RD in patients with and without cardiovascular manifestations. Methods Patients diagnosed with IgG4-RD who underwent a 2-[18F]FDG PET/CT scan were identified and classified based on presence or absence of cardiovascular disease. Clinical and laboratory data were extracted and compared to three 2-[18F]FDG PET/CT semi-quantitative parameters: maximum standardised uptake value (SUVmax), metabolic tumour volume (MTV), and total lesion glycolysis (TLG). Tissue-to-background blood (TBR) values were also evaluated for cardiovascular manifestations. These data were also compared in patients before and after receiving immunosuppressive therapy. Results Forty-six patients identified were divided into an eight member subgroup of patients with cardiovascular manifestations, and a thirty-eight member subgroup of patients without. Patients with cardiovascular lesions were most frequently identified incidentally on imaging evaluation for other diseases (37.5%), with none presenting with chest pain or other cardiovascular symptoms. Ten patients with pre-treatment and post-treatment 2-[18F]FDG PET/CT scans demonstrated significant decreases in all semi-quantitative parameters, with no significant decrease in total IgG or ESR. The decrease in SUVmax, MTV, TLG following therapy was replicated in patients with and without cardiovascular manifestations. Conclusion 2-[18F]FDG PET/CT is an important investigation to determine all sites of involvement in this multisystemic disease and to rule out life-threatening cardiovascular manifestations even in the absence of symptoms. Semi-quantitative parameters such as SUVmax, MTV, TLG, and TBR are useful in assessing treatment response in patients. There are no serological substitutes that can quantify the extent of disease involvement like 2-[18F]FDG PET/CT.https://doi.org/10.1186/s13550-023-00972-9PETIgG4-related diseaseCardiovascular disease
spellingShingle Mingwei Chen
Charlene Yu Lin Tang
Warren Weng Seng Fong
Winnie Wing-Chuen Lam
Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response
EJNMMI Research
PET
IgG4-related disease
Cardiovascular disease
title Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response
title_full Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response
title_fullStr Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response
title_full_unstemmed Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response
title_short Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response
title_sort semi quantitative indices of 2 18f fdg pet ct in assessing cardiovascular and non cardiovascular manifestations of igg4 related disease and treatment response
topic PET
IgG4-related disease
Cardiovascular disease
url https://doi.org/10.1186/s13550-023-00972-9
work_keys_str_mv AT mingweichen semiquantitativeindicesof218ffdgpetctinassessingcardiovascularandnoncardiovascularmanifestationsofigg4relateddiseaseandtreatmentresponse
AT charleneyulintang semiquantitativeindicesof218ffdgpetctinassessingcardiovascularandnoncardiovascularmanifestationsofigg4relateddiseaseandtreatmentresponse
AT warrenwengsengfong semiquantitativeindicesof218ffdgpetctinassessingcardiovascularandnoncardiovascularmanifestationsofigg4relateddiseaseandtreatmentresponse
AT winniewingchuenlam semiquantitativeindicesof218ffdgpetctinassessingcardiovascularandnoncardiovascularmanifestationsofigg4relateddiseaseandtreatmentresponse